Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Radiation Oncology

Phase 2 study of adjuvant radiotherapy following narrow‐margin hepatectomy in patients with HCC

Hepatology | Sep 23, 2021 Radiation Oncology

Metformin in combination with chemoradiotherapy in locally advanced non–small cell lung cancer

JAMA | Sep 22, 2021 Radiation Oncology

Pembrolizumab plus concurrent chemoradiation therapy for stage III non–small cell lung cancer

JAMA | Sep 22, 2021 Radiation Oncology

Trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in ERBB2-positive breast cancer

JAMA | Sep 22, 2021 Radiation Oncology

Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer

Cancer Epidemiology, Biomarkers & Prevention | Sep 18, 2021 Radiation Oncology

OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer

European Urology | Sep 16, 2021 Radiation Oncology

Clinical complications of chemotherapy and patient-reported outcomes after breast reconstruction

JAMA | Sep 13, 2021 Radiation Oncology

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

PLoS Medicine | Sep 09, 2021 Radiation Oncology

Combined 177Lu-PSMA-617 PRLT and abiraterone acetate vs 177Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability

The Prostate | Sep 09, 2021 Radiation Oncology

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

PLoS Medicine | Sep 04, 2021 Radiation Oncology

« Prev 1 2 3 4 5 6 7 … 82 Next »

Phase 2 study of adjuvant radiotherapy following narrow‐margin hepatectomy in patients with HCC

Metformin in combination with chemoradiotherapy in locally advanced non–small cell lung cancer

Pembrolizumab plus concurrent chemoradiation therapy for stage III non–small cell lung cancer

Trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in ERBB2-positive breast cancer

Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer

OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer

Clinical complications of chemotherapy and patient-reported outcomes after breast reconstruction

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

Combined 177Lu-PSMA-617 PRLT and abiraterone acetate vs 177Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Phase 2 study of adjuvant radiotherapy following narrow‐margin hepatectomy in patients with HCC

Metformin in combination with chemoradiotherapy in locally advanced non–small cell lung cancer

Pembrolizumab plus concurrent chemoradiation therapy for stage III non–small cell lung cancer

Trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in ERBB2-positive breast cancer

Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer

OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer

Clinical complications of chemotherapy and patient-reported outcomes after breast reconstruction

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

Combined 177Lu-PSMA-617 PRLT and abiraterone acetate vs 177Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic